Muqi Liu

ORCID: 0009-0007-7631-2798
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Immune Cell Function and Interaction
  • RNA modifications and cancer
  • Chemokine receptors and signaling
  • Ubiquitin and proteasome pathways
  • Ferroptosis and cancer prognosis
  • interferon and immune responses
  • Immunotherapy and Immune Responses
  • CRISPR and Genetic Engineering

Third Xiangya Hospital
2022-2025

Central South University
2022-2025

Xiangya Hospital Central South University
2023-2025

Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide, especially in advanced stages where limited treatment options result poor prognosis. The immunosuppressive tumor immune microenvironment (TIME), characterized by low cell infiltration and exhaustion, limits immunotherapy efficacy. To address this, our study investigates the role C-C motif chemokine ligand 3 (CCL3) modulating HCC TIME. Methods We analyzed CCL3 expression human samples from...

10.1136/jitc-2024-010947 article EN cc-by-nc-nd Journal for ImmunoTherapy of Cancer 2025-02-01

Hepatocellular carcinoma (HCC) resists immunotherapy due to its immunosuppressive microenvironment. Sarcoma homology 2 domain-containing protein tyrosine phosphatase-1 (SHP-1) inhibits T cell receptor signaling, and pharmacological inhibition is limited by poor selectivity membrane permeability. Here, we generated CRISPR-edited SHP-1-knockout (KO) CD8+ cells enhance adoptive therapy against HCC. Single-cell RNA sequencing of HCC patient revealed elevated SHP-1 in exhausted subsets. SHP-1-KO...

10.1016/j.isci.2025.112266 article EN cc-by-nc-nd iScience 2025-03-22

Tumor heterogeneity of immune infiltration cells plays a decisive role in hepatocellular carcinoma (HCC) therapy response and prognosis. This study investigated the effect different subtypes CD8+T on HCC tumor microenvironment about its

10.2174/0109298673274578231030065454 article EN Current Medicinal Chemistry 2023-11-08

Background: There is increasing evidence that protein ubiquitination plays crucial roles in adaptive immune response by regulating the function of T cells. Zinc finger 91 (ZFP91), as an E3 ubiquitin (Ub) ligase, has been shown to be associated with proliferation and activation mouse derived tumor infiltrating lymphocytes. However, whether it functions human cells underlying mechanism still need further exploration. Methods: We used lentivirus infection H9 cell lines primary reduce ZFP91...

10.1097/01.tp.0000994792.29238.3c article EN Transplantation 2023-10-01
Coming Soon ...